1. Home
  2. PSNL vs SCM Comparison

PSNL vs SCM Comparison

Compare PSNL & SCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • SCM
  • Stock Information
  • Founded
  • PSNL 2011
  • SCM 2012
  • Country
  • PSNL United States
  • SCM United States
  • Employees
  • PSNL N/A
  • SCM N/A
  • Industry
  • PSNL Medical Specialities
  • SCM Finance/Investors Services
  • Sector
  • PSNL Health Care
  • SCM Finance
  • Exchange
  • PSNL Nasdaq
  • SCM Nasdaq
  • Market Cap
  • PSNL 484.0M
  • SCM 412.9M
  • IPO Year
  • PSNL 2019
  • SCM 2012
  • Fundamental
  • Price
  • PSNL $4.60
  • SCM $14.64
  • Analyst Decision
  • PSNL Strong Buy
  • SCM Hold
  • Analyst Count
  • PSNL 5
  • SCM 1
  • Target Price
  • PSNL $7.90
  • SCM $13.00
  • AVG Volume (30 Days)
  • PSNL 1.1M
  • SCM 167.9K
  • Earning Date
  • PSNL 08-05-2025
  • SCM 08-06-2025
  • Dividend Yield
  • PSNL N/A
  • SCM 10.93%
  • EPS Growth
  • PSNL N/A
  • SCM 11.71
  • EPS
  • PSNL N/A
  • SCM 1.43
  • Revenue
  • PSNL $80,317,000.00
  • SCM $102,761,445.00
  • Revenue This Year
  • PSNL $0.45
  • SCM $0.36
  • Revenue Next Year
  • PSNL $25.75
  • SCM $2.94
  • P/E Ratio
  • PSNL N/A
  • SCM $10.20
  • Revenue Growth
  • PSNL 0.36
  • SCM N/A
  • 52 Week Low
  • PSNL $2.83
  • SCM $11.19
  • 52 Week High
  • PSNL $7.79
  • SCM $15.56
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 35.07
  • SCM 56.06
  • Support Level
  • PSNL $4.57
  • SCM $13.80
  • Resistance Level
  • PSNL $4.93
  • SCM $14.95
  • Average True Range (ATR)
  • PSNL 0.33
  • SCM 0.26
  • MACD
  • PSNL -0.08
  • SCM 0.03
  • Stochastic Oscillator
  • PSNL 30.65
  • SCM 81.36

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.

Share on Social Networks: